VOLITIONRX LTD - Common Stock, par value $0.001 per share (VNRX)

CUSIP: 928661107

Q4 2017 13F Holders as of 31 Dec 2017

Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
129,251,202
Total 13F shares
4,547,367
Share change
-122,760
Total reported value
$13,369,331
Price per share
$2.94
Number of holders
18
Value change
-$275,277
Number of buys
7
Number of sells
6

Quarterly Holders Quick Answers

What is CUSIP 928661107?
CUSIP 928661107 identifies VNRX - VOLITIONRX LTD - Common Stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of VNRX - VOLITIONRX LTD - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
Lagoda Investment Management, L.P.
13F
Company
2.6%
3,356,754
$8,828,000 30 Sep 2017
13F
Knoll Capital Management, LLC
13F
Company
0.36%
461,538
$1,242,000 30 Sep 2017
13F
Southpoint Capital Advisors LP
13F
Company
0.21%
265,482
$698,000 30 Sep 2017
13F
VANGUARD GROUP INC
13F
Company
0.16%
204,994
$540,000 30 Sep 2017
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.08%
100,890
$265,000 30 Sep 2017
13F
Leisure Capital Management
13F
Company
0.06%
73,233
$193,000 30 Sep 2017
13F
MORGAN STANLEY
13F
Company
0.05%
61,400
$161,000 30 Sep 2017
13F
Bank of New York Mellon Corp
13F
Company
0.02%
30,376
$80,000 30 Sep 2017
13F
NORTHERN TRUST CORP
13F
Company
0.02%
22,714
$60,000 30 Sep 2017
13F
GARRISON BRADFORD & ASSOCIATES INC
13F
Company
0.01%
15,500
$41,000 30 Sep 2017
13F
ROYAL BANK OF CANADA
13F
Company
0.01%
14,000
$37,000 30 Sep 2017
13F
Creative Planning
13F
Company
0.01%
13,200
$35,000 30 Sep 2017
13F
Advisor Group, Inc.
13F
Company
0.01%
11,500
$30,000 30 Sep 2017
13F
BlackRock Finance, Inc.
13F
Company
0.01%
10,983
$29,000 30 Sep 2017
13F
BESSEMER GROUP INC
13F
Company
0.01%
10,000
$26,000 30 Sep 2017
13F
Tower Research Capital LLC (TRC)
13F
Company
0.01%
6,832
$18,000 30 Sep 2017
13F
RBC Europe Ltd
13F
Company
0.01%
6,575
$17,292 30 Sep 2017
13F
UBS Group AG
13F
Company
0%
2,656
$7,000 30 Sep 2017
13F
CITIGROUP INC
13F
Company
0%
1,500
$4,000 30 Sep 2017
13F

Institutional Holders of VOLITIONRX LTD - Common Stock, par value $0.001 per share (VNRX) as of Q4 2017

As of 31 Dec 2017, VOLITIONRX LTD - Common Stock, par value $0.001 per share (VNRX) was held by 18 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 4,547,367 shares. The largest 10 holders included Lagoda Investment Management, L.P., Knoll Capital Management, LP, Vanguard Group Inc, BRIDGEWAY CAPITAL MANAGEMENT INC, GEODE CAPITAL MANAGEMENT, LLC, Leisure Capital Management, MORGAN STANLEY, NORTHERN TRUST CORP, GARRISON BRADFORD & ASSOCIATES INC, and ROYAL BANK OF CANADA. This page lists 18 institutional shareholders reporting positions in this security for the Q4 2017 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q4 2017 vs Q3 2017 Across Filers

Q3 2017 holders
19
Q4 2017 holders
18
Holder diff
-1
Investor Q3 2017 Shares Q4 2017 Shares Share Diff Share Chg % Q3 2017 Value $ Q4 2017 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .